| Financial Year |
March 31 2023 |
| Monetary Funds |
131,197,060.43 |
| Held-for-trading Financial Assets |
617,109.66 |
| Notes Receivable |
-- |
| Accounts Receivable |
377,344,169.17 |
| Advances to Suppliers |
9,216,733.01 |
| Other Receivables |
6,769,915.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
218,743,811.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,339,663.38 |
| Total Current Assets |
789,087,454.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
457,512,905.75 |
| Under-construction Projects |
121,357,790.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
77,001,590.50 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,012,105.04 |
| Deferred Income Tax Assets |
4,883,942.68 |
| Other Non-Current Assets |
21,426,233.59 |
| Sub-Total of Non-Current Assets |
701,194,568.38 |
| Total Assets |
1,490,282,022.59 |
| Short-Term Loans |
244,229,076.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
59,195,445.47 |
| Accounts Payable |
116,326,856.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,872,118.55 |
| Taxes Payable |
4,668,014.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,137,257.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
132,700.58 |
| Sub-Total of Current Liabilities |
442,582,242.82 |
| Long-term Loans |
102,104,823.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,810,275.93 |
| Deferred Income Tax Liabilities |
33,774,255.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
138,689,355.45 |
| Total Liabilities |
581,271,598.27 |
| Paid-In Capital(Or Share Stock) |
225,000,000.00 |
| Capital Surplus |
280,314,199.70 |
| Surplus Reserve |
53,254,117.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
350,431,169.46 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
909,010,424.32 |
| Owner's Equity（Stockholder's Equity） |
909,010,424.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,490,282,022.59 |
